Abstract
OTK18 is a C2H2 type zinc finger protein expressed by human macrophages following HIV infection. OTK18 possesses antiretroviral activity, and its processing products accumulate in the cytoplasm of perivascular brain macrophages in advanced HIV encephalitis cases. Since the regulation of OTK18 expression in living patients following human immunodeficiency virus-1 (HIV-1) infection is unknown, our objective is to investigate the first cohort study on OTK18 protein levels in living patients. We assessed OTK18 levels in plasma and cerebrospinal fluid (CSF) in 44 living patients with or without HIV-1 infection, with diverse demographic and clinical background. A novel high-sensitivity OTK18 ELISA system was developed to measure OTK18 levels in CSF and plasma using custom made biotinylated monoclonal antibodies against OTK18. The correlation of OTK18 levels with epidemiological parameters was statistically analyzed. Multiple linear regression modeling suggested that plasma OTK18 levels for HIV-1-positive subjects were only about one sixth of that for HIV-1-negative subjects. Higher CD8 T-cell counts were associated with higher levels of OTK18. Using proportional odds logistic regression, we showed that HIV-1-positive patients have significantly lower OTK18 in CSF samples, but we did not observe significant correlation between CD8 T-cell counts and CSF OTK18 levels. OTK18 levels in both plasma and CSF are significantly lower in HIV-1-positive subjects as compared to HIV-1-negative subjects. Plasma OTK18 levels are positively correlated to CD8 T-cell counts, independent of HIV-1 status.
This is a preview of subscription content, log in via an institution to check access.
References
Carlson K, Leisman G, Limoges J, Pohlman G, Horiba M, Buescher J et al (2004a) Molecular characterization of a putative anti-retroviral transcriptional factor, OTK18. J Immunol 172:381–391
Carlson KA, Limoges J, Pohlman GD, Poluektova LY, Langford D, Masliah E et al (2004b) OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J Neuroimmunol 150:186–198, doi:10.1016/j.jneuroim.2004.01.021
Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M et al (1997) The neuropathogenesis of the AIDS dementia complex. AIDS 11:S35–S45, doi:10.1097/00002030-199705000-00001
Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley series in probability and statistics. Wiley, New York
Hussain LA, Lehner T (1995) Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85:475–484
Kleinbaum D, Kupper L, Muller K, Nizam A (1997) Applied regression analysis and other multivariable methods, 3rd edn. Duxbury, Pacific Grove
Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517–524, doi:10.1002/ana.410190602
Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H et al (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5:3226–3245, doi:10.1002/pmic.200500358
Ping P, Vondriska TM, Creighton CJ, Gandhi TK, Yang Z, Menon R et al (2005) A functional annotation of subproteomes in human plasma. Proteomics 5:3506–3519, doi:10.1002/pmic.200500140
Price RW, Deeks SG (2004) Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: clinical and pathogenetic implications for the central nervous system. J Neurovirol 10(Suppl 1):44–51
Saito H, Fujiwara T, Takahashi EI, Shin S, Okui K, Nakamura Y (1996) Isolation and mapping of a novel human gene encoding a protein containing zinc-finger structures. Genomics 31:376–379, doi:10.1006/geno.1996.0062
Sewell AK, Price DA, Oxenius A, Kelleher AD, Phillips RE (2000) Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape. Stem Cells 18:230–244, doi:10.1634/stemcells.18-4-230
Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM et al (2005a) HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis 191:890–898, doi:10.1086/428095
Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG et al (2005b) Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis 5:98, doi:10.1186/1471-2334-5-98
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67–73, doi:10.1177/108705719900400206
Acknowledgments
We would like to thank Drs. J. Anderson and H. Gendelman for suggestions and critical reading of the manuscript and Russell Swan and Meg Maquart for manuscript editing. This work is supported in part by NIH Grants R01 AI5089401, R01 MH072539, and NCRR P20RR15635 (T.I.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buescher, J.L., Duan, F., Sun, J. et al. OTK18 Levels in Plasma and Cerebrospinal Fluid Correlate with Viral Load and CD8 T-cells in Normal and AIDS Patients. J Neuroimmune Pharmacol 3, 230–235 (2008). https://doi.org/10.1007/s11481-008-9125-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-008-9125-3